In addition, we analysed the cytotoxic activity of the CTLs against the SOX2-positive primary GBM cell preparations DD-HT4 and DD-HT6559 expressing HLA-A2 as determined by PCR and FACS analysis (data not shown). This evidence concerns the gene SOX2 and glioblastoma.